FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Watson Laboratories Necon 1/35-28 Recall

Necon 1/35-28 (norethindrone and ethinyl estradiol) Tablets USP, 1 mg/35 mcg, inert tab…

Watson Laboratories Inc · Corona, CA

Risk level
Class II
Reported by FDA
Oct 31, 2012
Recall ID
D-017-2013
Check your lot numberHow we source this data

Summary

Watson Laboratories recalled Necon 1/35-28 starting Oct 19, 2012. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-017-2013 on Oct 31, 2012. Reason: Cross Contamination With Other Products: The firm recalled Zovia, Lutera, Necon, and Zenchent, because certain lots could potentially be contaminated with trace amounts of Hydrochlorothiazide (HCTZ). Status: Terminated.

Why it was recalled

Cross Contamination With Other Products: The firm recalled Zovia, Lutera, Necon, and Zenchent, because certain lots could potentially be contaminated with trace amounts of Hydrochlorothiazide (HCTZ).

Product description

Necon 1/35-28 (norethindrone and ethinyl estradiol) Tablets USP, 1 mg/35 mcg, inert tablets, 28-count tablets per dispenser packaged in 6 Tablet Dispensers per carton, Rx only, Manufactured by: Watson Pharma, Inc., A subsidiary of Watson Pharmaceuticals, Inc., Corona, CA 92880 USA; NDC 52544-552-28.

Lot numbers, UPCs & expiration codes

Lot #: 514743AB, Exp 09/30/13

Where it was sold

Nationwide and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-017-2013
Classification
Class II
Status
Terminated
Recall initiated
Oct 19, 2012
FDA report date
Oct 31, 2012
Quantity
6,466 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Watson Laboratories Inc

Original FDA data

Every field from FDA enforcement report D-017-2013, exactly as published.

Show all FDA fields
City
Corona
State
CA
Status
Terminated
Country
United States
Event ID
63509
Address
311 Bonnie Cir
Code information
Lot #: 514743AB, Exp 09/30/13
Postal code
92880-2882
Report date
Oct 31, 2012
Product type
Drugs
Recall number
D-017-2013
Classification
Class II
Recalling firm
Watson Laboratories Inc
Product quantity
6,466 cartons
Termination date
Nov 21, 2013
Reason for recall
Cross Contamination With Other Products: The firm recalled Zovia, Lutera, Necon, and Zenchent, because certain lots could potentially be contaminated with trace amounts of Hydrochlorothiazide (HCTZ).
Voluntary / mandated
Voluntary: Firm initiated
Product description
Necon 1/35-28 (norethindrone and ethinyl estradiol) Tablets USP, 1 mg/35 mcg, inert tablets, 28-count tablets per dispenser packaged in 6 Tablet Dispensers per carton, Rx only, Manufactured by: Watson Pharma, Inc., A subsidiary of Watson Pharmaceuticals, Inc., Corona, CA 92880 USA; NDC 52544-552-28.
Distribution pattern
Nationwide and Puerto Rico
Recall initiation date
Oct 19, 2012
Initial firm notification
Letter
Center classification date
Oct 24, 2012

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-017-2013, published Oct 31, 2012. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls